IL-38 and IL-36 Target Autophagy for Regulating Synoviocyte Proliferation, Migration, and Invasion in Rheumatoid Arthritis

被引:10
|
作者
Hao, Zhe [1 ]
Liu, Yi [1 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Rheumatol & Immunol, Chengdu 610041, Sichuan, Peoples R China
关键词
CELLS; RECEPTOR;
D O I
10.1155/2021/7933453
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Rheumatoid arthritis (RA) is an autoimmune disease leading to severe joint damage and disability. Fibroblast-like synoviocytes (FLSs) mostly contribute to the joint inflammation and destruction in RA through distinct mechanisms. However, little is known about newly discovered interleukin- (IL-) 36 and IL-38 involving in the pathology of RA. Here, we assessed the effect of IL-36 and IL-38 on RA-FLS function using IL-36 and IL-38 overexpression plasmids. We found that IL-36 inhibited synoviocytes proliferation while IL-38 showed an opposite influence. Furthermore, IL-36 and IL-38 significantly sequestered or accelerated RA-FLS migration and invasion capacity, respectively. Mechanically, IL-36 and IL-38 targeted autophagy for RA-FLS modulation. Using autophagy inhibitor 3-MA and inducer compound rapamycin, we found that autophagy negatively regulated the survival, migration, and invasion of synovial cells. Based on these results, IL-38 in combination with autophagy inhibitor 3-MA treatment demonstrated the strongest blockage of the above three activities of RA-FLS, and IL-38 overexpression reversed rapamycin-inhibited cell proliferation, migration, and invasion. Moreover, injection of IL-36 can improve the symptoms of RA in a rat model of RA. Taken together, we conclude that IL-38 and IL-36 target autophagy for regulating synoviocyte proliferation, migration, and invasion in RA.
引用
收藏
页数:11
相关论文
共 12 条
  • [1] The complex roles of IL-36 and IL-38 in cancer: friends or foes?
    Finucane, Meabh
    Brint, Elizabeth
    Houston, Aileen
    ONCOGENE, 2025, 44 (13) : 851 - 861
  • [2] IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist
    van de Veerdonk, Frank L.
    Stoeckman, Angela K.
    Wu, Gouping
    Boeckermann, Aaron N.
    Azam, Tania
    Netea, Mihai G.
    Joosten, Leo A. B.
    van der Meer, Jos W. M.
    Hao, Ruyi
    Kalabokis, Vassili
    Dinarello, Charles A.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (08) : 3001 - 3005
  • [3] Distinct expression of interleukin (IL)-36α, β and γ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease
    Boutet, M. -A.
    Bart, G.
    Penhoat, M.
    Amiaud, J.
    Brulin, B.
    Charrier, C.
    Morel, F.
    Lecron, J. -C.
    Rolli-Derkinderen, M.
    Bourreille, A.
    Vigne, S.
    Gabay, C.
    Palmer, G.
    Le Goff, B.
    Blanchard, F.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2016, 184 (02) : 159 - 173
  • [4] The Emerging Roles of IL-36, IL-37, and IL-38 in Diabetes Mellitus and its Complications
    Huang, Guoqing
    Li, Mingcai
    Tian, Xiaoqing
    Jin, Qiankai
    Mao, Yushan
    Li, Yan
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2022, 22 (10) : 997 - 1008
  • [5] IL-36, IL-37, and IL-38 Cytokines in Skin and Joint Inflammation: A Comprehensive Review of Their Therapeutic Potential
    Boutet, Marie-Astrid
    Nerviani, Alessandra
    Pitzalis, Costantino
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (06)
  • [6] Pro- and anti-inflammatory roles of interleukin (IL)-33, IL-36, and IL-38 in inflammatory bowel disease
    Andoh, Akira
    Nishida, Atsushi
    JOURNAL OF GASTROENTEROLOGY, 2023, 58 (02) : 69 - 78
  • [7] IL-38 alleviates airway remodeling in chronic asthma via blocking the profibrotic effect of IL-36γ
    Zhang, Min
    Zhou, Jian-Xia
    Huang, Chu-Qin
    Feng, Kang-Ni
    Zou, Xiao-Ling
    Cen, Jie-Mei
    Meng, Ping
    Li, Hong-Tao
    Zhang, Tian-Tuo
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2023, 214 (03) : 260 - 274
  • [8] Environmental, inflammatory, and anti-inflammatory squad in acne vulgaris pathogenesis: AhR, IL-36, and IL-38
    El Esawy, Fatma Mohamed
    Mohammed, Shuzan Ali
    Nasar, Ebtesam Nasar Zargon
    Mostafa, Sara Hemdan
    Elhabak, Doaa M.
    JOURNAL OF COSMETIC DERMATOLOGY, 2022, 21 (07) : 3038 - 3045
  • [9] Long noncoding RNA H19 alleviates inflammation in osteoarthritis through interactions between TP53, IL-38, and IL-36 receptor
    Zhou, Y.
    Li, J.
    Xu, F.
    Ji, E.
    Wang, C.
    Pan, Z.
    BONE & JOINT RESEARCH, 2022, 11 (08): : 594 - 607
  • [10] Whether full-length IL-38 acts as a promoter or inhibitor in activating rheumatoid arthritis fibroblast-like synoviocytes depends on IL-1β
    Ding, Yudan
    Shao, Ju
    Liu, Cai
    Li, Zhengtong
    Zhang, Yuping
    Jie, Ligang
    Zhu, Xiaotong
    Liang, Bibo
    Yu, Qinghong
    Wu, Jing
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2024, 27 (01)